For outreach programs to grow and thrive, industry experts at the conference emphasized that labs need the support of senior hospital executives. In a keynote presentation titled “Know Your Numbers,” Michael Metzler, the former COO of St. Elizabeth’s Medical Center (Boston) and CEO of St. Anne’s Hospital (Fall River, Mass.), provided a valuable window into the mind of a CEO considering a move into outreach testing. Metzler prefaced his discussion of how to make the business case for outreach with a warning. “The lab must have a reputation for excellence before outreach can be sold to the CEO,” he said. “Weaknesses must be fixed before making the case for outreach.”

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

July 2009 - Table of Contents

LIR July 2009 (full PDF issue)

G-2 Reports-Chi Solutions’ Outreach Survey Indicates Labs Leading in Profitability Measures, Falling Short on Bad Debt and DSO

LabCorp Plans to Acquire Monogram Biosciences for Approximately $155 Million

Senate Bill Proposes ‘Date of Service’ Policy Change That Will Benefit Labs

Genoptix, Myriad Genetics Lead in G-2 Reports’ First Quarter Benchmarking Analysis

Psychemedics Teams With UK’s Bupa to Market Hair Analysis Assay

Inside the Lab Industry: Washington G-2 Reports-Chi Solutions’ Latest Survey Finds Outreach Lab Profitability Over 20% and Annual Revenue Growth Over 3%

The C-Suite Perspective: Building a Business Case for Outreach

Agendia Boosts MammaPrint Sales Effort Through CLIA Lab Launch, Sales Force Expansion

GE’s $100 Million Stimulus Simplicity Program to Offer No-Interest Loans for EMR Products

CBLPath Opens Manhattan Facility

Adeona Pharma Buys Chicago’s Hartlab to Expand Degenerative Disease Diagnostic Offerings

Lab Stocks Continue Impressive Show of Strength; Up 11% Over Five Weeks, 32% Over Past 13 Weeks

Industry Buzz: CDC Seeks Help in Establishing Laboratory Best Practices